Sarcopenia, Frailty, and Diabetes in Older Adults.

Populations are aging and the prevalence of diabetes mellitus is increasing tremendously. The number of older people with diabetes is increasing unexp...
275KB Sizes 1 Downloads 8 Views

Recommend Documents


Counteracting the Trajectory of Frailty and Sarcopenia in Older Adults.
Food preservation technologies and medical advances in the past 50 years have contributed to safeguarding the health and prolonging the lives of individuals worldwide. However, living longer does not automatically equate with being healthy, living in

Sarcopenia and frailty in older patients with diabetes mellitus.
Sarcopenia is defined as age-associated loss of muscle mass and function, and is frequently accompanied by diabetes mellitus (DM) in older adults. Some of the mechanisms of the development of sarcopenia including insulin resistance, chronic inflammat

[Sarcopenia and frailty in neurology].
Sarcopenia and frailty are common geriatric syndromes and are associated with adverse health outcome and impaired health-related quality of life. Co-occurrences of these two syndromes with age-related neurological diseases are potentially high but no

Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults.
There is emerging evidence of the role of diabetes as a risk factor for frailty. However, the mechanisms of this association are uncertain.

Sarcopenia and frailty in elderly trauma patients.
Sarcopenia describes a loss of muscle mass and resultant decrease in strength, mobility, and function that can be quantified by CT. We hypothesized that sarcopenia and related frailty characteristics are related to discharge disposition after blunt t

Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes.
To determine whether the protective effect of metformin against death is modified by frailty status in older adults with type 2 diabetes.

Frailty and inflammatory markers in older adults with cancer.
We examined the associations between frailty and inflammatory markers, in particular neutrophil lymphocyte ratio (NLR), in elderly cancer patients. We conducted cross-sectional analyses of data derived from the Carolina Seniors Registry (CSR), a data

Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia.
Population aging is rapidly accelerating worldwide; however, longer life expectancy is not the only public health goal. Indeed, extended lifetime involves maintaining function and the capacity of living independently. Sarcopenia and physical frailty